UBS Group upgraded shares of Ambu A/S (OTCMKTS:AMBBY – Free Report) to a strong-buy rating in a research report sent to investors on Tuesday morning,Zacks.com reports.
Ambu A/S Stock Performance
Shares of AMBBY stock opened at $15.25 on Tuesday. The company has a debt-to-equity ratio of 0.08, a current ratio of 2.60 and a quick ratio of 1.47. The company’s fifty day moving average price is $16.89 and its two-hundred day moving average price is $16.96. The firm has a market capitalization of $3.58 billion, a P/E ratio of 89.71 and a beta of 1.45. Ambu A/S has a 12 month low of $13.02 and a 12 month high of $22.65.
Ambu A/S (OTCMKTS:AMBBY – Get Free Report) last issued its quarterly earnings results on Wednesday, May 7th. The company reported $0.10 earnings per share (EPS) for the quarter. Ambu A/S had a net margin of 5.69% and a return on equity of 5.67%.
About Ambu A/S
Ambu A/S develops, produces, and sells medical devices to hospitals, clinics, and rescue services worldwide. The company offers anaesthesia, and patient monitoring and diagnostics products. The company also offers endoscopy products, such as bronchoscopes, rhinolaryngoscopes, duodenoscopes, cystoscopes, and display units; and neurology products, including EEG and EMG electrodes, EMG guided injections, and intraoperative monitoring products.
Featured Articles
- Five stocks we like better than Ambu A/S
- Stock Market Holidays 2022-2025 – Here’s When the NYSE and NASDAQ Will be Closed
- Walmart Stock Alert: Big Price Move Expected Soon
- Buy P&G Now, Before It Sets A New All-Time High
- An Acquisition Just Made Dick’s the Most Exciting Stock in Retail
- Investing in Commodities: What Are They? How to Invest in Them
- Microsoft and OpenAI Just Hit Reset—Here’s Why MSFT Stock Wins
Receive News & Ratings for Ambu A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ambu A/S and related companies with MarketBeat.com's FREE daily email newsletter.
